TO

Translational Oncology

Translational Oncology publishes novel research investigations that bridge laboratory and clinical settings, including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis, and treatment of human cancers, with the goal of improving clinical care for oncology patients.

Looking to publish in Translational Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 4.1
Quartile Q2
Open Access Type Open
ISSN 1936-5233
eISSN 1936-5233
Invitation Only No
Cost Range Article Publishing Charge: USD 3880 excluding taxes.

Submission Instructions

Translational Oncology accepts the following article types. Click on an article type to view submission instructions.

Original Research Article

Cover Letter A cover letter is required. The cover letter must be on official letterhead with the author's institution logo and must not include funding information, author declarations, or suggested or opposed reviewers.
Abstract An abstract is required. Abstract must not exceed 250 words. Structured.
Manuscript Manuscript must not exceed 4,500 words. The manuscript must be divided into Introduction, Materials and Methods, Results, and Discussion. Keywords must be provided, and the declarations tool must be completed with any required generative AI disclosure.
References No more than 50 references may be included. References cited in the article must appear in the reference list, references in the reference list must be cited in the article, and references cited in the abstract must be given in full.
Figures & Tables No more than 6 figures and/or tables should be included. Figures and other graphical media must be supplied as separate files, and tables must be submitted as editable text. Tables, footnotes, and captions must be included in the submitted files.
Reformat to Translational Oncology using Livewrite Premium

Review Article

Cover Letter Cover Letter requirements are not specified.
Abstract Required. The abstract must not exceed 250 words. Unstructured.
Manuscript The manuscript must not exceed 4,500 words. The manuscript should include an introduction, discussion, and conclusion. Up to 5 authors are allowed without prior agreement of the editors.
References No more than 80 references may be included. Any references cited in the article must appear in the reference list, and any references listed must be cited in the article.
Figures & Tables No more than 6 figures and/or tables may be included.
Reformat to Translational Oncology using Livewrite Premium

Letters To The Editors

Cover Letter A cover letter is required. The cover letter must be on official letterhead with the logo from the author's institution.
Abstract An abstract must not be included.
Manuscript The manuscript must not exceed 1,000 words. The manuscript should be divided into clearly defined sections using headings. The manuscript should include keywords, acknowledgements in a separate section before the references, and a generative AI disclosure if applicable.
References No more than 10 references may be included. Any references cited in the article must appear in the reference list and references cited in the abstract must be given in full.
Figures & Tables No more than 1 figure and/or table may be included. Figures and tables must be supplied with the manuscript, and tables must be submitted as editable text rather than images. Tables, footnotes, and captions must be included in the submitted files.
Reformat to Translational Oncology using Livewrite Premium

Recent Publications

Progesterone induces steroidome and lipidome remodeling in a BRCA-resembling mouse model of high-grade serous ovarian cancer

Elisabeth M. Schwiebert, Albert Vega-Herrera, Andro Botros, Samuel G. Moore, David A. Gaul, Olga Kim, Jaeyeon Kim, Facundo M. Fernández

10.1016/j.tranon.2026.102837
View Publication

Advances in deciphering intratumoral versus peritumoral heterogeneity of infiltrating lymphocytes in pancreatic cancer: a spatial perspective

Ke Zhao, Qiting Yang, Yuhan Yan, Jiyun Zhu, Siming Zheng

10.1016/j.tranon.2026.102823
View Publication

Advanced radiotherapy and systemic therapy in head and neck adenoid cystic carcinoma: Current progress and future integrated strategies

Lihao Liu, Xiaoding Zhou, Lu Li, Jinxin Yang, Mingyu Tan

10.1016/j.tranon.2026.102841
View Publication

The SMAC-mimetic xevinapant differentially enhances cisplatin and immune checkpoint blockade efficacy in high-risk HPV-positive tumors

Tsung-You Tsai, Mutsuki Kawabe, Arisa Nishikawa Kaga, Kento Okamoto, Jeffrey N. Myers, Abdullah A. Osman

10.1016/j.tranon.2026.102839
View Publication

RNA-Based and DNA-Based Next-Generation Sequencing of KIT and PDGFRA Mutations in Gastrointestinal Stromal Tumors: Analytical Performance and Epidemiologic Insights

Soumya Jaladi, Saba Alvand, Beth A. Pitel, Jesse S. Voss, Rohini Mopuri, Numrah Fadra, Sham Sunder, Mazen A. Atiq, Jaime Davila, Sounak Gupta, Benjamin R. Kipp, Kevin C. Halling

10.1016/j.tranon.2026.102812
View Publication

Frequently asked questions

How long does it take to publish?

Proof corrections are requested within two days. The journal also uses single anonymized peer review with a minimum of two reviewers for suitable submissions.

Reformat to Translational Oncology using Livewrite Premium

Is a cover letter required?

A cover letter should be included with submission. It should be on official institutional letterhead, be short and focused, and should not include funding information, author declarations, or suggested or opposed reviewers.

Reformat to Translational Oncology using Livewrite Premium

What are the publication costs?

Open access journal with no subscription charges; an Article Publishing Charge of USD 3880 excluding taxes is payable for all articles.

Reformat to Translational Oncology using Livewrite Premium

Research Topics

Cancer Immunotherapy and Biomarkers Ferroptosis and cancer prognosis Cancer Cells and Metastasis Cancer-related molecular mechanisms research Cancer, Hypoxia, and Metabolism RNA modifications and cancer MicroRNA in disease regulation Cancer Genomics and Diagnostics Lung Cancer Treatments and Mutations Immunotherapy and Immune Responses Pancreatic and Hepatic Oncology Research Immune cells in cancer Epigenetics and DNA Methylation Radiomics and Machine Learning in Medical Imaging Glioma Diagnosis and Treatment Circular RNAs in diseases Immune Cell Function and Interaction Cancer-related Molecular Pathways Cancer, Lipids, and Metabolism Ubiquitin and proteasome pathways Lung Cancer Research Studies CAR-T cell therapy research MRI in cancer diagnosis Head and Neck Cancer Studies Extracellular vesicles in disease

Related Journals

KI
Kidney International Supplements Elsevier BV
CO
Current Opinion In Pharmacology Elsevier BV
AJ
American Journal Of Ophthalmology Elsevier BV
CI
Clinics In Chest Medicine Elsevier BV
CI
Chemico-biological Interactions Elsevier BV
BP
Best Practice & Research Clinical Endocrinology & Metabolism Elsevier BV